We evaluated four subcutaneous ICD configurations in 78 patients who were candidates for ICD implantation and subsequently tested the best configuration in 49 additional patients to determine the ...

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...

Randomized controlled trials have demonstrated the superiority of implantable cardioverter ... short-term clinical follow-up trials of a subcutaneous ICD, all sponsored by the device manufacturer.

The FDA today approved the Subcutaneous Implantable Defibrillator (S-ICD) system from Cameron Health.The device is the first ICD that does not require a lead that connects directly to the heart ...

HRS: iPad2 Can Trigger Magnet Mode in Defibrillators The subcutaneous implantable cardioverter-defibrillator (S-ICD System) is both safe and effective for the treatment of life-threatening ...

The Subcutaneous Implantable Cardioverter‑Defibrillator System Post Approval Study (S‑ICD PAS), which observed patients with subcutaneous implantable cardioverter-defibrillators (S‑ICDs ...

The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia ...

Among a total of 393,734 ICD implants (mean age, 67 years; 28% women), 0.9% (n = 3,717) were subcutaneous ICDs. The rate of subcutaneous ICDs increased from 0.2% in fourth quarter of 2012 to 1.9% ...

Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped ...

In 2021, Amsterdam UMC was the first in Europe to implant this wireless pacemaker that communicates with a subcutaneous ICD. This implantation took place at the beginning of the global Modular ATP ...